New research reports that hair loss is uncommon among people taking GLP-1 weight-loss and diabetes drugs, but the risk is not zero. A study described by Euronews and Global News (Canada), published in BMJ, compares people with type 2 diabetes taking GLP-1 receptor stimulants against those using other diabetes medicines, including SGLT-2 and DPP-4 drugs. The study finds that the overall likelihood of hair loss is “low,” yet higher in GLP-1 users than in the comparison groups. The New York Post similarly characterizes the risk as rare but real, noting that the increase remains significant compared with other diabetes treatments.
Across the coverage, the findings are consistent: hair loss occurs at a low rate for people using GLP-1 drugs, whether for obesity or diabetes, but it appears at a higher frequency than with certain other diabetes medication classes. The reports do not indicate that GLP-1 drugs cause hair loss in all users, but they suggest patients and clinicians should be aware of this side effect when considering or continuing treatment.
